Mice vaccinated with live cells expressing prostate-specific membrane antigen (PSMA) generate antibodies against PSMA-positive prostate tumors, an international research team has demonstrated. The team also
Patients with chronic lymphocytic leukemia with a polymorphism of the P2X7 receptor gene, especially those with mutated VH genes, have better survival compared with other
People who take vitamin E regularly are less likely than those in the general population to die of bladder cancer, researchers report, but it is
An experimental regimen of low-dose thalidomide and the steroid prednisone was effective against anemia and thrombocytopenia in a three-month pilot study enrolling 21 patients who
Treatment strategies using letrozole as first-line therapy for advanced breast cancer provide significantly higher quality-adjusted survival than does treatment with tamoxifen. Study author Beth H.
Addition of carboplatin (Paraplatin) to trastuzumab (Herceptin) plus paclitaxel (Taxol) can enhance significantly treatment response and time to disease progression with acceptable toxicity for women
An investigational therapeutic dendritic vaccine is well tolerated, stimulates immunity, and is showing signs of clinical benefit in patients with advanced metastatic HER-2 positive breast
Preliminary results from two European trials raise the possibility that combining imatinib mesylate (Gleevec) with pegylated interferon alpha 2b (Peg IFN alpha/PegIntron) or cytabarine (Ara-C)
Weekly administration of 40,000 units of recombinant human erythropoietin (rHuEPO) reduces allogeneic red blood cell (RBC) transfusion and increases haemoglobin in critically ill patients. Researchers
According to results of a population-based study, continuous combined HRT is associated with an increased risk for breast cancer among postmenopausal women, however the risk
Cell Therapeutics Inc. (CTI) said on Monday preliminary results of a phase II study testing Trisenox (arsenic trioxide) as a stand-alone therapy indicate the drug
The European Commission has granted marketing approval for a once weekly regimen of NeoRecormonÒ (epoetin beta) in anaemia related to cancer. This approval was based
לפי ידיעה שהועברה אלינו ע”י חברת נוברטיס, אושר הגליבק בשוויץ כטיפול קו ראשון למבוגרים וילדים בלאוקמיה. קישור ל-PDF
במרכז יטופלו צוללנים שנחשפו לחומרים מסוכנים בקישון; גופם ינוקה ממתכות בשיטה גרמנית חדשנית; היזם – איש שייטת שלקה ב-3 סוגי סרטן; מחר ייערך בהיכל התרבות
Researchers who tested three licensed software systems designed to help radiologists decipher mammograms have determined that, overall, the commercial products do the job. “The good
According to preliminary results from the “once-only sigmoidoscopy” (SCORE) trial, a single sigmoidoscopy screening at about 60 years of age may provide a safe and
The FDA just approved Taxotere® (docetaxel) for the first-line treatment of non-small cell lung cancer (NSCLC), making it the only chemotherapy agent approved for newly
Japan’s Health Ministry said on Thursday it has received reports of 81 deaths among cancer patients linked to use of new lung cancer drug Iressa.
בדיון שהתקיים בבית המשפט בעקבות תביעתה של חולה לספק לה הרצפטין (Herceptin ) קבע בית המשפט שלמרות שהכללת התכשיר בסל הבריאות מותווית לחולות סרטן שד
The United States Preventive Services Task Force (USPSTF) has found insufficient evidence to recommend for or against prostate cancer screening, according to clinical guidelines published